The Cardiovascular Care Group
The Cardiovascular Care Group is a physician-owned New Jersey vascular surgery practice founded in 1963, operating from seven offices with 19 board-certified surgeons and hospital affiliations, delivering diagnosis and treatment of arterial and venous disease to patients across the state.
- Company typePrivate
- Founded1963
- HeadquartersWestfield, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What The Cardiovascular Care Group does
The Cardiovascular Care Group (TCVCG) is a physician-owned, private vascular surgery professional corporation headquartered in Westfield, New Jersey, founded in 1963 as one of the first professional medical corporations in the state. It operates as New Jersey's largest vascular surgery group dedicated solely to arterial and venous disease, employing 19 board-certified vascular surgeons supported by physician assistants, nurse practitioners, and licensed vascular technologists across seven office locations in Westfield, Clifton, Denville, Hoboken, Morristown, Newark, and Shrewsbury, plus a business office in Springfield. The practice maintains surgical affiliations with eight major New Jersey hospital systems, including Morristown Medical Center, Overlook Medical Center, Newark Beth Israel Medical Center, and Cooperman Barnabas Medical Center.
TCVCG's service portfolio spans diagnosis and treatment of peripheral artery disease (PAD), carotid artery disease, aortic aneurysms, hemodialysis access, and venous disease. Its diagnostic backbone is an IAC-accredited Noninvasive Vascular Laboratory (accredited since 1995, Gold Milestone 2025) performing over 3,000 examinations annually via ultrasound without radiation exposure. Treatment delivery is anchored by AAAASF-accredited outpatient Procedure Suites in Westfield and Clifton for same-day minimally invasive vascular procedures (angiogram, angioplasty, atherectomy, stenting, IVC filter placement), with the Vein Institute of New Jersey operating as a wholly-owned sub-brand focused on venous conditions. The group also runs a Vascular Clinical Trials Center partnered with Abbott, Medtronic, Cook Medical, BD/Bard, AngioDynamics, Humacyte, and Preserve, and in January 2026 launched The Care Screen, a standalone noninvasive vascular screening program targeting asymptomatic at-risk patients.
The business model is fee-for-service clinical care billed through major commercial payors (Aetna, AmeriHealth, Cigna, Clover PPO, Horizon, Oxford, United Healthcare) and Medicare — all TCVCG physicians participate in Medicare — supplemented by clinical trial research revenue and CareCredit patient financing. Patient acquisition is sales-led, combining physician referrals, hospital affiliations, community screening events, and self-referrals supported by content marketing (blog, eBook library), telemedicine pilots, and an Aprima-based patient portal. No external funding, private equity ownership, or public market activity is indicated.
The Cardiovascular Care Group firmographics
Firmographics- Name
- The Cardiovascular Care Group
- Legal name
- The Cardiovascular Care Group
- Website
- https://tcvcg.com
- Company type
- Private
- Founded year
- 1963
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Cardiovascular Care Group is a physician-owned New Jersey vascular surgery practice founded in 1963, operating from seven offices with 19 board-certified surgeons and hospital affiliations, delivering diagnosis and treatment of arterial and venous disease to patients across the state.
- Ownership category
- akta.pro rank
The Cardiovascular Care Group industry classification
Industry- Product category
- Vascular Surgery Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621), All Other Outpatient Care Centers (621498), Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)
- akta.pro secondary industry
- Single-Specialty ASCs (HLAFAIAB)
Keywords
Where The Cardiovascular Care Group is headquartered
LocationHeadquarters
- HQ city
- Westfield
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
The Cardiovascular Care Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Services Revenue: Fee-for-service medical services billed through insurance plans including Medicare, Aetna, AmeriHealth, Cigna, Clover PPO, Horizon, Oxford, and United Healthcare. All physicians participate in Medicare program.
- Clinical Trials: Participation in vascular clinical trials in partnership with pharmaceutical and medical device companies (Abbott, AngioDynamics, Cook Medical, Bard, Humacyte, Medtronic, Preserve) providing research revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Per visit | Insurance/Medicare patients |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
The Cardiovascular Care Group product offering
Product offeringCore offering
The Cardiovascular Care Group (TCVCG) is New Jersey's largest vascular surgery group, providing comprehensive diagnosis and treatment of arterial and venous diseases. The practice offers noninvasive vascular diagnostics, minimally invasive office-based procedures in an AAAASF-accredited Procedure Suite, hospital-based vascular surgery, dialysis access creation and maintenance, and specialized vein treatment through its Vein Institute of New Jersey subsidiary. Services span peripheral artery disease, carotid artery disease, aortic aneurysms, hemodialysis access, and chronic venous insufficiency.
Product overview
The Cardiovascular Care Group is a single, unified vascular surgery practice offering comprehensive diagnosis and management of arterial and venous diseases. The practice operates as an integrated platform combining multiple service lines: core vascular surgery consultations and treatments, the Vein Institute of New Jersey (a sub-brand acquired in 2013) for specialized vein care, a AAAASF-accredited Procedure Suite for outpatient minimally invasive procedures, an IAC-accredited Noninvasive Vascular Laboratory for diagnostic imaging, The Care Screen (launched January 2026) for proactive vascular screening, vascular clinical trials, telemedicine services, and digital patient resources including an eBook library and Patient Portal. The practice has seven office locations throughout New Jersey and maintains hospital affiliations with major regional medical centers.
Differentiator
Problem solved
Functional benefit
Products and services
- The Cardiovascular Care Group (TCVCG) Vascular Practice
- The Vein Institute of New Jersey
- Noninvasive Vascular Laboratory
- The Care Screen Vascular Screening Program
- Procedure Suite (Outpatient Endovascular)
- Vascular Clinical Trials Center
- Vascular Conditions Treatment Services
- Hospital Consult Services
- Patient Portal (Aprima)
- Telemedicine Services
Quantifiable outcome
- Over 98% patient satisfaction scores in Procedure Suite
- +1 more outcomes
Companies that use The Cardiovascular Care Group
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles5 records
The Cardiovascular Care Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
The Cardiovascular Care Group partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered minor and core.
- AbbottminorMedical device company partner in clinical trials for vascular disease treatments and technologies.
- AngioDynamicsminorMedical device company partner in clinical trials for vascular technologies.
- Cook MedicalminorMedical device company partner in clinical trials for vascular treatments.
- Bard (BD)minorMedical device company partner in clinical trials for vascular disease treatments.
- HumacyteminorBiotechnology company partner in clinical trials for vascular access technologies.
- MedtronicminorMedical device company partner in clinical trials for vascular technologies and devices.
- Preserve (IVC Filters)minorMedical device company partner in clinical trials for IVC filter technologies.
- Clara Maass Medical CentercoreHospital affiliation for vascular surgery procedures and patient care in Belleville, NJ.
- Hackensack University Hospital at MountainsidecoreHospital affiliation for vascular surgery procedures in Montclair, NJ.
- Morristown Medical CentercoreMajor hospital affiliation for vascular surgery procedures and patient care.
- Newark Beth Israel Medical CentercoreHospital affiliation with dedicated vascular services and noninvasive vascular laboratory.
- Overlook Medical CentercoreHospital affiliation for vascular surgery procedures in Summit, NJ.
- Robert Wood Johnson University Hospital at RahwaycoreHospital affiliation for vascular surgery procedures in Rahway, NJ.
- Cooperman Barnabas Medical CentercoreHospital affiliation for vascular surgery procedures in Livingston, NJ.
- Trinitas Regional Medical CenterminorHospital affiliation for vascular surgery procedures in Elizabeth, NJ.
- Atlantic Health SystemcorePartnership with Atlantic Health System hospitals including Overlook Medical Center for clinical trials and dialysis symposiums.
Scale indicators5 records
Recent moves15 records
Expansion highlights5 records
The Cardiovascular Care Group competitors and assessment
Company assessmentDirect peers
- Center for Vein Restoration: The largest physician-led vein treatment provider in the US with 100+ locations. Directly comparable to TCVCG's Vein Institute of New Jersey sub-brand in offering specialized venous disease diagnosis and treatment (sclerotherapy, laser, surgical vein care).
- USA Vein Clinics: National outpatient vein treatment clinic network with multiple NJ locations. Comparable in office-based vein disease treatment, vascular screening, and minimally invasive procedures, competing for the same self-referral patient pool.
- Vein Clinics of America: Multi-state network of physician-owned vein treatment clinics offering sclerotherapy, endovenous laser, and other venous procedures. Comparable to TCVCG's Vein Institute sub-brand in service mix and target patient segments.
- New Jersey Vein and Vascular Center: Regional NJ-based vascular and vein practice offering similar arterial and venous disease diagnosis and treatment. Direct competitor in the same geography with overlapping service lines including PAD, varicose veins, and screening programs.
Broad incumbents
- MedStar Heart & Vascular Institute: Large multi-state academic vascular and cardiovascular program with research-driven vascular surgery practice. Comparable to TCVCG in offering IAC-accredited vascular labs, clinical trials, and comprehensive arterial/venous disease management, though at much larger scale.
- Cleveland Clinic Vascular Surgery: Academic tertiary vascular surgery program within a national health system offering the full spectrum of vascular care including endovascular AAA repair, TCAR, and complex PAD interventions. Comparable as a high-acuity vascular referral center with research program.
- Atlantic Medical Group Vascular Surgery: Hospital-employed vascular surgery group within Atlantic Health System (parent of Overlook, Morristown Medical Center). Competitor for hospital-based surgical cases and increasingly for outpatient referrals in the same NJ geography as TCVCG.
- RWJBarnabas Health Vascular Services: Large NJ health system with employed vascular surgeons across multiple hospitals (including Newark Beth Israel, Cooperman Barnabas). Comparable endovascular and open surgical vascular care, competing for inpatient cases and referrals.
Regional players
- CardioVascular Associates of New York: Large independent multi-specialty cardiovascular and vascular practice based in the New York metro area. Comparable in offering comprehensive peripheral vascular, carotid, and aortic care as an independent physician-owned group adjacent to TCVCG's NJ geography.
Others
- Society for Vascular Surgery (SVS) Member Practices Network: National professional society representing board-certified vascular surgeons. TCVCG's surgeons' leadership roles in SVS position the practice within this peer ecosystem; comparable vascular groups frequently benchmarked include large academic and community vascular surgery programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
The Cardiovascular Care Group social profiles
Digital presenceThe Cardiovascular Care Group compliance and trust
Trust signalCompliance3 records
The Cardiovascular Care Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Cardiovascular Care Group leadership team
Management profileNumber of profiles
Profiles1 record
The Cardiovascular Care Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
The Cardiovascular Care Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Cardiovascular Care Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Cardiovascular Care Group
What does The Cardiovascular Care Group do?
The Cardiovascular Care Group (TCVCG) is New Jersey's largest vascular surgery group, providing comprehensive diagnosis and treatment of arterial and venous diseases. The practice offers noninvasive vascular diagnostics, minimally invasive office-based procedures in an AAAASF-accredited Procedure Suite, hospital-based vascular surgery, dialysis access creation and maintenance, and specialized vein treatment through its Vein Institute of New Jersey subsidiary. Services span peripheral artery disease, carotid artery disease, aortic aneurysms, hemodialysis access, and chronic venous insufficiency.
Is The Cardiovascular Care Group a public or private company?
The Cardiovascular Care Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was The Cardiovascular Care Group founded?
The Cardiovascular Care Group was founded in 1963. It employs 51 to 100 people.
Where is The Cardiovascular Care Group based?
The Cardiovascular Care Group is headquartered in Westfield, United States, in the North America region.
How does The Cardiovascular Care Group make money?
Two revenue lines are on record. Clinical Services Revenue is the primary driver. The others are clinical Trials.
Who are The Cardiovascular Care Group's main competitors?
Direct peers on record are Center for Vein Restoration, USA Vein Clinics, Vein Clinics of America and New Jersey Vein and Vascular Center. Broad incumbents are MedStar Heart & Vascular Institute, Cleveland Clinic Vascular Surgery, Atlantic Medical Group Vascular Surgery and RWJBarnabas Health Vascular Services. CardioVascular Associates of New York is listed as a regional player. Society for Vascular Surgery (SVS) Member Practices Network is listed as an others.
Does The Cardiovascular Care Group have an API?
No public API is recorded for The Cardiovascular Care Group.
What industry is The Cardiovascular Care Group in?
The Cardiovascular Care Group's product category is Vascular Surgery Services. Its primary akta.pro industry code is HLAKABAG, Vascular Medicine (Peripheral Arterial/Venous Disease), with a secondary code of HLAFAIAB, Single-Specialty ASCs. Its NAICS code is 62111 and its SIC code is 8011.